Protea Biosciences Group Inc. reported earnings results for the third quarter and nine months ended Sept. 30, 2016. For the quarter, the company reported revenue of $519,908. The net loss for the third quarter of 2016 was $1,494,790, a decrease of 6% compared to the third quarter of 2015. Net cash used in operations was $568,194 a reduction of 46% in comparison to the third quarter of 2015. For the nine months, revenue of $1,577,010, an increase of 24% over the first nine months of 2015. The loss from operations for the first nine months of 2016 was $4,496,322, a 19% reduction compared to the first nine months of 2015. Net cash used in operating activities for the nine months ended September 30, 2016 totaled $3,408,885, a 21% reduction in the net cash used in operations in comparison to the first nine months of 2015.